Developer docs
API playgroundTry for free, no card

Search company profiles

TBG Diagnostics

Full company profile

uuid000jntc

Namestring
TBG Diagnostics
Legal namestring
TBG Biotechnology Corp.
Websiteurl
tbgbio.com
Company typeenum
Public
Founded yearint
2006
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToowong, Australia
HQ citystring
Toowong
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
HLA typing reagents, molecular diagnostics, immunogenetics testing, transplant diagnostics, genetic testing kits
Industry5 codes
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Laboratories621511
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
Molecular Diagnostics Reagents
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1HLA Typing Reagents and Kits
TypeOne Time License
Description

Sale of molecular diagnostic reagents including QzTGSO Nanopore kits, QzNGS Illumina kits, HLAssure SBT kits, ExProbe qPCR kits, and Morgan SSP kits for HLA, HPA, and KIR typing. Products are sold in kit formats with various test counts (24-96 tests per kit). Revenue: $2.33 million.

defenseworld.net
2Laboratory Services
TypeProfessional Services
Description

TBG Molecular Typing Laboratory provides HLA-typing services with quality assurance, including participation in international proficiency testing programs. Also offers customized genetic testing solutions and welcomes global laboratory partnerships.

tbgbio.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Pricing details1 tier
1Reagent kits sold in standard package sizes
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Product catalog and flyers available for download. Clinical user and distributor sections require login authentication. No public pricing displayed.

tbgbio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1QzTGSO
Description

Third Generation Sequencing (TGS) HLA typing kits using Oxford Nanopore Technologies sequencer for full-length amplicon phasing with 4-hour turnaround time

tbgbio.com
+9 more records
Core offering1 text field

TBG Diagnostics manufactures and sells molecular diagnostic reagent kits for HLA, HPA, and KIR gene typing across five technology platforms: SSP (gel electrophoresis), SBT (Sanger sequencing), qPCR (real-time PCR), NGS (Illumina), and TGS (Oxford Nanopore). The portfolio is complemented by proprietary analysis software, modular automation hardware (DX-A systems), and ASHI-certified laboratory typing services for clinical labs, transplant centers, and blood banks.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Single sample Turn Around Time within 4 hours with TGS Nanopore platform
+4 more records
Product overview1 text field

TBG Biotechnology Corp. is a molecular diagnostics company focused on immunogenetics, offering a comprehensive portfolio of HLA (Human Leukocyte Antigen), HPA (Human Platelet Antigen), and KIR gene typing products. The product ecosystem spans five technology platforms: QzTGSO (Third Generation Sequencing using Oxford Nanopore), QzNGS (Next Generation Sequencing using Illumina), HLAssure SBT (Sanger Sequence Based Typing), ExProbe (Real Time PCR/qPCR), and Morgan (Sequence Specific Primers with gel electrophoresis). Each platform is supported by corresponding analysis software (QzTGStype, QzNGStype, AccuType, and ExProbeType) for data interpretation. The portfolio also includes automation hardware (DX-A Autopipetting System, DX-A Mini TGS Library Prep) and laboratory services, providing end-to-end solutions for transplantation, transfusion, autoimmunity, drug hypersensitivity, and genetic disease testing including NIPT, Thalassemia, Sickle Cell Anemia, SMA, and Fragile X Syndrome.

Product and service8 records
1QzTGSO Typing Kits
CategoryHLA Typing Reagents
Description

Third Generation Sequencing (TGS) HLA typing kits designed to run on Oxford Nanopore Technologies sequencers, providing full-length amplicon phasing and 100% fully phased results within 4 hours for clinical HLA typing laboratories and transplant centers.

2QzNGS Typing Kits
CategoryHLA Typing Reagents
Description

Next Generation Sequencing kits using Illumina sequencers for high resolution HLA typing with pair-end short reads enabling long distance phasing for ultra-high throughput processing (up to 384 barcodes per run).

3HLAssure SBT Kits
CategoryHLA Typing Reagents
Description

Sequence Based Typing kits using Sanger sequencing with Group Specific Amplification (GSA) primers for high resolution HLA genotyping across A, B, C, DRB1, DQB1, DPB1, DRB3/4/5, DQA1, DPA1, and HPA loci. Includes IVD clearance for European CE, Taiwan FDA, and China FDA.

4ExProbe Typing Kits
CategoryHLA Typing Reagents
Description

Real Time PCR (qPCR) typing kits for rapid HLA, HPA, and KIR allele detection with results within 2 hours, using TaqMan or Melting Curve Analysis formats across multiple real-time PCR instrument platforms.

5Morgan HLA SSP Kits
CategoryHLA Typing Reagents
Description

Sequence Specific Primer kits using agarose gel electrophoresis for low-medium resolution HLA typing, providing the most economical solution for low-throughput processing with results within 3.5 hours.

6DX-A Autopipetting System
CategoryLaboratory Automation Hardware
Description

Modular automation pipettor system weighing under 25 kg that can be linked together for flexible and scalable automated sample dilution and processing, reducing hands-on time and human variability.

7DX-A Mini TGS Library Prep
CategoryLaboratory Automation Hardware
Description

Compact automated TGS library preparation system smaller than a microwave oven, processing up to 32 samples in a single run with reduced hands-on time and high efficiency.

8TBG Molecular Typing Laboratory Services
CategoryLaboratory Services
Description

ASHI-certified HLA-typing services with highest level of quality assurance, participation in international proficiency testing programs, and customized genetic testing solutions offered through global laboratory partnerships.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Asian Society for Clinical Pathologist and Laboratory Medicine (ASCPaLM)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-10-02
Description

TBG Biotechnology serves as the host/organizer for ASCPaLM 2026 conference to be held at Taipei International Convention Center. TBG's President delivers remarks welcoming members to the society's global platform for collaboration, innovation, and excellence in clinical pathology and laboratory medicine.

tbgbio.com
Strategic tierCoreTypeTechnology or Integration
Description

Oxford Nanopore Technologies supplies the sequencer platform for TBG's QzTGSO Typing Kits. TBG products use ONT's MinION flow cell technology which can be reloaded up to 6 times. TBG recommends purchasing Nanopore equipment and consumables directly from local ONT suppliers.

Strategic tierCoreTypeTechnology or Integration
Description

Illumina provides the sequencing platform for TBG's QzNGS Typing Kits. The pair-end short read technology from Illumina enables cost-efficient high throughput testing. TBG recommends purchasing Illumina equipment from authorized suppliers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

HistoGenetics is an ASHI-accredited reference laboratory providing high-resolution HLA typing services. Directly comparable to TBG's TBG Molecular Typing Laboratory service business serving transplant and research customers globally.

TypeDirect peer
Description

Omixon offers Holotype HLA NGS kits and the HLA Twin software platform for clinical HLA typing. Directly comparable to TBG's NGS workflow offering and a peer in software-driven immunogenetics analysis.

TypeDirect peer
Description

Through its One Lambda business, Thermo Fisher is the global market leader in HLA typing reagents and transplant diagnostics, offering LABType SSO, SeCore SBT, and AlleleSEQR PCR products. Directly comparable to TBG as a reagent vendor for clinical HLA typing labs.

TypeEmerging player
Description

Scisco Genetics offers HLA and KIR SSP typing kits primarily for research and clinical labs. A niche molecular HLA reagent peer with similar low-to-medium resolution offering to TBG's Morgan SSP kit line.

TypeDirect peer
Description

GenDx specializes in NGS-based HLA and KIR typing reagents (NGmix, AlleleID) along with analysis software (SBTengine, NGSengine). A near-direct competitor to TBG's QzNGS and HLAssure SBT product lines in transplant labs.

TypeBroad incumbent
Description

QIAGEN provides molecular diagnostic reagents, sample prep kits, and HLA-related assays as part of a broad life sciences portfolio. Comparable to TBG on molecular diagnostic reagents and laboratory automation, though HLA is not its primary focus.

TypeBroad incumbent
Description

CareDx is a transplant-focused diagnostics company offering AlloMap and AlloSure along with lab services for transplant centers. Comparable as a transplant diagnostics peer though operating more downstream in patient monitoring rather than donor-recipient HLA typing.

TypeDirect peer
Description

Immucor (acquired by Stago) provides transfusion and transplant diagnostics including HLA serology and molecular reagents for blood banks and transplant centers. Directly comparable to TBG on HLA/HPA reagents for transfusion and transplant labs.

TypeDirect peer
Description

Bio-Rad offers the HLA SSO and Luminex-based typing products (formerly Bio-Rad/AbD Serotec) used widely in transplant and immunogenetics labs. Competes head-to-head with TBG's SSP, SBT, and NGS HLA kits across clinical laboratories worldwide.

TypeDirect peer
Description

BAG Diagnostics provides HLA typing kits based on SSP and SSO methods for clinical and research labs. Comparable as a niche HLA reagent vendor competing with TBG's Morgan SSP and HLAssure product lines, particularly in Europe.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TBG Diagnostics

Molecular Diagnostics Reagentstbgbio.com

TBG Diagnostics firmographics

Firmographics
Name
TBG Diagnostics
Legal name
TBG Biotechnology Corp.
Website
https://tbgbio.com
Company type
Public
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

TBG Diagnostics industry classification

Industry
Product category
Molecular Diagnostics Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAHAAAM
IVD Reagents, Assay Kits & Consumables (Non-instrument)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHLAAALAH
Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing)
SECONDARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAHAAAN
Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • HLA typing reagents
  • Molecular diagnostics
  • Immunogenetics testing
  • Transplant diagnostics
  • Genetic testing kits

Where TBG Diagnostics is headquartered

Location

Headquarters

HQ city
Toowong
HQ country
Australia
HQ region
Oceania

Offices1 record

Markets served

TBG Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. HLA Typing Reagents and Kits: Sale of molecular diagnostic reagents including QzTGSO Nanopore kits, QzNGS Illumina kits, HLAssure SBT kits, ExProbe qPCR kits, and Morgan SSP kits for HLA, HPA, and KIR typing. Products are sold in kit formats with various test counts (24-96 tests per kit). Revenue: $2.33 million.
  2. Laboratory Services: TBG Molecular Typing Laboratory provides HLA-typing services with quality assurance, including participation in international proficiency testing programs. Also offers customized genetic testing solutions and welcomes global laboratory partnerships.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goReagent kits sold in standard package sizes

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

TBG Diagnostics product offering

Product offering

Core offering

TBG Diagnostics manufactures and sells molecular diagnostic reagent kits for HLA, HPA, and KIR gene typing across five technology platforms: SSP (gel electrophoresis), SBT (Sanger sequencing), qPCR (real-time PCR), NGS (Illumina), and TGS (Oxford Nanopore). The portfolio is complemented by proprietary analysis software, modular automation hardware (DX-A systems), and ASHI-certified laboratory typing services for clinical labs, transplant centers, and blood banks.

Product overview

TBG Biotechnology Corp. is a molecular diagnostics company focused on immunogenetics, offering a comprehensive portfolio of HLA (Human Leukocyte Antigen), HPA (Human Platelet Antigen), and KIR gene typing products. The product ecosystem spans five technology platforms: QzTGSO (Third Generation Sequencing using Oxford Nanopore), QzNGS (Next Generation Sequencing using Illumina), HLAssure SBT (Sanger Sequence Based Typing), ExProbe (Real Time PCR/qPCR), and Morgan (Sequence Specific Primers with gel electrophoresis). Each platform is supported by corresponding analysis software (QzTGStype, QzNGStype, AccuType, and ExProbeType) for data interpretation. The portfolio also includes automation hardware (DX-A Autopipetting System, DX-A Mini TGS Library Prep) and laboratory services, providing end-to-end solutions for transplantation, transfusion, autoimmunity, drug hypersensitivity, and genetic disease testing including NIPT, Thalassemia, Sickle Cell Anemia, SMA, and Fragile X Syndrome.

Differentiator

Problem solved

Functional benefit

Brands

  • QzTGSO: Third Generation Sequencing (TGS) HLA typing kits using Oxford Nanopore Technologies sequencer for full-length amplicon phasing with 4-hour turnaround time
  • QzNGS
  • HLAssure
  • Morgan
  • ExProbe
  • DX-A Autopipetting System
  • DX-A Mini TGS Library Prep
  • QzTGStype
  • AccuType
  • ExProbeType

Products and services

  • QzTGSO Typing Kits Third Generation Sequencing (TGS) HLA typing kits designed to run on Oxford Nanopore Technologies sequencers, providing full-length amplicon phasing and 100% fully phased results within 4 hours for clinical HLA typing laboratories and transplant centers.
  • QzNGS Typing Kits Next Generation Sequencing kits using Illumina sequencers for high resolution HLA typing with pair-end short reads enabling long distance phasing for ultra-high throughput processing (up to 384 barcodes per run).
  • HLAssure SBT Kits Sequence Based Typing kits using Sanger sequencing with Group Specific Amplification (GSA) primers for high resolution HLA genotyping across A, B, C, DRB1, DQB1, DPB1, DRB3/4/5, DQA1, DPA1, and HPA loci. Includes IVD clearance for European CE, Taiwan FDA, and China FDA.
  • ExProbe Typing Kits Real Time PCR (qPCR) typing kits for rapid HLA, HPA, and KIR allele detection with results within 2 hours, using TaqMan or Melting Curve Analysis formats across multiple real-time PCR instrument platforms.
  • Morgan HLA SSP Kits Sequence Specific Primer kits using agarose gel electrophoresis for low-medium resolution HLA typing, providing the most economical solution for low-throughput processing with results within 3.5 hours.
  • DX-A Autopipetting System Modular automation pipettor system weighing under 25 kg that can be linked together for flexible and scalable automated sample dilution and processing, reducing hands-on time and human variability.
  • DX-A Mini TGS Library Prep Compact automated TGS library preparation system smaller than a microwave oven, processing up to 32 samples in a single run with reduced hands-on time and high efficiency.
  • TBG Molecular Typing Laboratory Services ASHI-certified HLA-typing services with highest level of quality assurance, participation in international proficiency testing programs, and customized genetic testing solutions offered through global laboratory partnerships.

Quantifiable outcome

  • Single sample Turn Around Time within 4 hours with TGS Nanopore platform
  • +4 more outcomes

Companies that use TBG Diagnostics

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

TBG Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability1 record

Feature8 records

TBG Diagnostics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • Asian Society for Clinical Pathologist and Laboratory Medicine (ASCPaLM)flagshipStrategic or Co-development Partner · 2 October 2025TBG Biotechnology serves as the host/organizer for ASCPaLM 2026 conference to be held at Taipei International Convention Center. TBG's President delivers remarks welcoming members to the society's global platform for collaboration, innovation, and excellence in clinical pathology and laboratory medicine.
  • Oxford Nanopore Technologies (ONT)coreTechnology or IntegrationOxford Nanopore Technologies supplies the sequencer platform for TBG's QzTGSO Typing Kits. TBG products use ONT's MinION flow cell technology which can be reloaded up to 6 times. TBG recommends purchasing Nanopore equipment and consumables directly from local ONT suppliers.
  • IlluminacoreTechnology or IntegrationIllumina provides the sequencing platform for TBG's QzNGS Typing Kits. The pair-end short read technology from Illumina enables cost-efficient high throughput testing. TBG recommends purchasing Illumina equipment from authorized suppliers.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

TBG Diagnostics competitors and assessment

Company assessment

Direct peers

  • HistoGenetics: HistoGenetics is an ASHI-accredited reference laboratory providing high-resolution HLA typing services. Directly comparable to TBG's TBG Molecular Typing Laboratory service business serving transplant and research customers globally.
  • Omixon: Omixon offers Holotype HLA NGS kits and the HLA Twin software platform for clinical HLA typing. Directly comparable to TBG's NGS workflow offering and a peer in software-driven immunogenetics analysis.
  • Thermo Fisher Scientific (One Lambda): Through its One Lambda business, Thermo Fisher is the global market leader in HLA typing reagents and transplant diagnostics, offering LABType SSO, SeCore SBT, and AlleleSEQR PCR products. Directly comparable to TBG as a reagent vendor for clinical HLA typing labs.
  • GenDx: GenDx specializes in NGS-based HLA and KIR typing reagents (NGmix, AlleleID) along with analysis software (SBTengine, NGSengine). A near-direct competitor to TBG's QzNGS and HLAssure SBT product lines in transplant labs.
  • Immucor: Immucor (acquired by Stago) provides transfusion and transplant diagnostics including HLA serology and molecular reagents for blood banks and transplant centers. Directly comparable to TBG on HLA/HPA reagents for transfusion and transplant labs.
  • Bio-Rad Laboratories: Bio-Rad offers the HLA SSO and Luminex-based typing products (formerly Bio-Rad/AbD Serotec) used widely in transplant and immunogenetics labs. Competes head-to-head with TBG's SSP, SBT, and NGS HLA kits across clinical laboratories worldwide.
  • BAG Diagnostics: BAG Diagnostics provides HLA typing kits based on SSP and SSO methods for clinical and research labs. Comparable as a niche HLA reagent vendor competing with TBG's Morgan SSP and HLAssure product lines, particularly in Europe.

Emerging players

  • Scisco Genetics: Scisco Genetics offers HLA and KIR SSP typing kits primarily for research and clinical labs. A niche molecular HLA reagent peer with similar low-to-medium resolution offering to TBG's Morgan SSP kit line.

Broad incumbents

  • QIAGEN: QIAGEN provides molecular diagnostic reagents, sample prep kits, and HLA-related assays as part of a broad life sciences portfolio. Comparable to TBG on molecular diagnostic reagents and laboratory automation, though HLA is not its primary focus.
  • CareDx: CareDx is a transplant-focused diagnostics company offering AlloMap and AlloSure along with lab services for transplant centers. Comparable as a transplant diagnostics peer though operating more downstream in patient monitoring rather than donor-recipient HLA typing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

TBG Diagnostics social profiles

Digital presence

TBG Diagnostics compliance and trust

Trust signal

Compliance5 records

TBG Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TBG Diagnostics leadership team

Management profile

Number of profiles

TBG Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TBG Diagnostics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TBG Diagnostics

What does TBG Diagnostics do?

TBG Diagnostics manufactures and sells molecular diagnostic reagent kits for HLA, HPA, and KIR gene typing across five technology platforms: SSP (gel electrophoresis), SBT (Sanger sequencing), qPCR (real-time PCR), NGS (Illumina), and TGS (Oxford Nanopore). The portfolio is complemented by proprietary analysis software, modular automation hardware (DX-A systems), and ASHI-certified laboratory typing services for clinical labs, transplant centers, and blood banks.

Is TBG Diagnostics a public or private company?

TBG Diagnostics is a public company. It is classified as public and is currently operating.

When was TBG Diagnostics founded?

TBG Diagnostics was founded in 2006. It employs 11 to 50 people.

Where is TBG Diagnostics based?

TBG Diagnostics is headquartered in Toowong, Australia, in the Oceania region.

How does TBG Diagnostics make money?

Two revenue lines are on record. HLA Typing Reagents and Kits are the primary driver. The others are laboratory Services.

Who are TBG Diagnostics's main competitors?

Direct peers on record are HistoGenetics, Omixon, Thermo Fisher Scientific (One Lambda), GenDx, Immucor, Bio-Rad Laboratories and BAG Diagnostics. Scisco Genetics is listed as an emerging player. Broad incumbents are QIAGEN and CareDx.

Does TBG Diagnostics have an API?

No public API is recorded for TBG Diagnostics.

What industry is TBG Diagnostics in?

TBG Diagnostics's product category is Molecular Diagnostics Reagents. Its primary akta.pro industry code is HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument), with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals